Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase.
about
ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adductsThe histone mark H3K36me3 regulates human DNA mismatch repair through its interaction with MutSĪ±Methylator-induced, mismatch repair-dependent G2 arrest is activated through Chk1 and Chk2DNA mismatch repair: molecular mechanism, cancer, and ageingThe accumulation of MMS-induced single strand breaks in G1 phase is recombinogenic in DNA polymerase beta defective mammalian cellsCharacterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2Structural, molecular and cellular functions of MSH2 and MSH6 during DNA mismatch repair, damage signaling and other noncanonical activitiesEarly Chk1 phosphorylation is driven by temozolomide-induced, DNA double strand break- and mismatch repair-independent DNA damageN-nitroso-N-ethylurea activates DNA damage surveillance pathways and induces transformation in mammalian cells.Treatment of pituitary carcinomas and atypical pituitary adenomas: a reviewHIV-1 Vpr-induced apoptosis is cell cycle dependent and requires Bax but not ANTAnti-proliferative activity of the quassinoid NBT-272 in childhood medulloblastoma cellsHuman MLH1 protein participates in genomic damage checkpoint signaling in response to DNA interstrand crosslinks, while MSH2 functions in DNA repairA new isoquinolinium derivative, Cadein1, preferentially induces apoptosis in p53-defective cancer cells with functional mismatch repair via a p38-dependent pathway.Residual gammaH2AX foci as an indication of lethal DNA lesions.Embryonic lethality after combined inactivation of Fancd2 and Mlh1 in mice.Nuclear reorganization of DNA mismatch repair proteins in response to DNA damage.Interactions of human mismatch repair proteins MutSalpha and MutLalpha with proteins of the ATR-Chk1 pathway.E1B and E4 oncoproteins of adenovirus antagonize the effect of apoptosis inducing factorThe mismatch repair system modulates curcumin sensitivity through induction of DNA strand breaks and activation of G2-M checkpoint.Mismatch repair proteins are activators of toxic responses to chromium-DNA damage.Histone/protein deacetylase SIRT1 is an anticancer therapeutic target.Interaction between human mismatch repair recognition proteins and checkpoint sensor Rad9-Rad1-Hus1Genomic and epigenetic instability in colorectal cancer pathogenesis.ASCIZ regulates lesion-specific Rad51 focus formation and apoptosis after methylating DNA damage.HOXA10 is associated with temozolomide resistance through regulation of the homologous recombinant DNA repair pathway in glioblastoma cell lines.Genotype to phenotype: analyzing the effects of inherited mutations in colorectal cancer families.Targeting and processing of site-specific DNA interstrand crosslinks.Loss of DNA mismatch repair imparts a selective advantage in planarian adult stem cells.Human pluripotent stem cells have a novel mismatch repair-dependent damage response.Lynch syndrome-associated mutations in MSH2 alter DNA repair and checkpoint response functions in vivo.The Rad50S allele promotes ATM-dependent DNA damage responses and suppresses ATM deficiency: implications for the Mre11 complex as a DNA damage sensor.Selenium compounds activate ATM-dependent DNA damage response via the mismatch repair protein hMLH1 in colorectal cancer cells.O6-Methylguanine DNA lesions induce an intra-S-phase arrest from which cells exit into apoptosis governed by early and late multi-pathway signaling network activation.Surgical resection of malignant gliomas-role in optimizing patient outcome.Phosphorylated hMSH6: DNA mismatch versus DNA damage recognition.Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer.Major differences between tumor and normal human cell fates after exposure to chemotherapeutic monofunctional alkylatorTherapeutic modulation of epigenetic drivers of drug resistance in ovarian cancer.DNA mismatch repair proteins are required for efficient herpes simplex virus 1 replication
P2860
Q24337520-8D9F066D-83A1-4FEE-BBA9-F28FC3E3BCC8Q24339204-392D0697-1FF8-4A31-9DED-16CDE6B61ED1Q24556572-EC93BA05-AF74-4CB9-A7C3-3FF4F18BA04CQ24647002-BEF085B5-0635-4138-8848-65F008263F84Q24794005-3AE484BA-6CD0-46D9-A606-F9498DD02B86Q28277364-6C388B39-65C8-450E-8640-2380E48098C0Q28285134-DA4027C6-F516-462D-BEDB-F5AEBF2437D7Q28487714-8C13EB48-67E9-4CA3-B2EA-916504DE404DQ30413046-B1CCCEE3-6C62-4459-8AAA-706C19A5F385Q30872897-38C80E58-CD9A-4525-B1E9-4A07FFFE12E5Q33265220-E3332EBE-3BF9-4BB9-9A4D-ACBA3A649B37Q33270402-71AF3C84-01D8-46C3-BEE7-A437EAEC08A0Q33369080-6DDC84D1-4914-4722-AF70-992532F74BFCQ33516915-66D7D7D9-D9B4-4E74-AA1A-571D23DB321AQ33522060-4F294325-A951-488F-AC2C-CC55519D6098Q33561045-1C03B7CD-BB97-4980-B43E-B4DD050A91A4Q33643516-1C7918B7-92A5-4C35-8D47-023415DF453BQ33648599-72AD0CBF-D675-45B2-A1D2-DE3610B7A861Q33708518-F23E6279-D399-4294-BB7E-C118B43ED85AQ33721800-7118E0B6-E947-4A81-BFEE-47D3B36C5101Q33758325-A2E85BD7-94A5-4CA7-8BCA-06177F564515Q33785586-6D4D05C9-59D9-46E6-AE65-1E4E3191269FQ33812133-62D62FF0-3464-4D3A-8A06-99AFC7643A70Q33836026-6EC9A0EF-B0A4-4CAE-9FFE-0FA01FD5B242Q33893554-C2C1BCDA-FE2C-45E9-A55D-C073DD163264Q33925330-D26B1F22-0063-4A3A-84B4-61298882CB51Q33939068-97DD54BD-EB9D-4A2D-A613-9041046A6553Q33952673-2F49A435-75B4-4D1C-8B50-EF0FE211D777Q33958108-5E85741D-9542-43C4-8A24-FFC9219F8A86Q34107260-913222A3-3078-4B77-B684-33B7118361A7Q34164054-59D3C7FE-4CE1-48FC-9E6E-C6A230D95DBAQ34227095-9E67E2E4-0DE6-4214-ADE0-5E31FDD2F07CQ34236531-6AF2D71E-E023-48F6-B78F-2C9CBF0C5D7AQ34293997-8374BE9E-57C4-47FF-A608-B7879A03A4A8Q34324963-FE57C719-DC76-46C0-96E9-07FB0C1918C5Q34441558-CFD57F3C-18C3-49DB-9211-398AE937DABFQ34728470-40A94FDD-5D4A-40E5-B454-2CA25FAD2072Q34982828-73D990F3-CA07-4855-B9E9-AB19B5DB3F3AQ35076298-09C3F4A2-540D-4486-BD59-D68AA8651F3AQ35531558-5137312B-3FE0-4042-84CB-D7840936B8F5
P2860
Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase.
description
2004 nĆ® lÅ«n-bĆ»n
@nan
2004 Õ©ÕøÖÕ”ÕÆÕ”Õ¶Õ« Õ
ÕøÖÕ¶Õ«Õ½Õ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕøÖÕ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ ÕµÖ
Õ¤ÕøÖÕ”Õ®
@hyw
2004 Õ©Õ¾Õ”ÕÆÕ”Õ¶Õ« Õ°ÕøÖÕ¶Õ«Õ½Õ«Õ¶ Õ°ÖÕ”ÕæÕ”ÖÕ”ÕÆÕ¾Õ”Õ® Õ£Õ«ÕæÕ”ÕÆÕ”Õ¶ Õ°ÕøÕ¤Õ¾Õ”Õ®
@hy
2004幓ć®č«ę
@ja
2004幓č«ę
@yue
2004幓č«ę
@zh-hant
2004幓č«ę
@zh-hk
2004幓č«ę
@zh-mo
2004幓č«ę
@zh-tw
2004幓č®ŗę
@wuu
name
Mismatch repair-dependent G2 c ...... gents requires the ATR kinase.
@ast
Mismatch repair-dependent G2 c ...... gents requires the ATR kinase.
@en
type
label
Mismatch repair-dependent G2 c ...... gents requires the ATR kinase.
@ast
Mismatch repair-dependent G2 c ...... gents requires the ATR kinase.
@en
prefLabel
Mismatch repair-dependent G2 c ...... gents requires the ATR kinase.
@ast
Mismatch repair-dependent G2 c ...... gents requires the ATR kinase.
@en
P2093
P2860
P356
P1433
P1476
Mismatch repair-dependent G2 c ...... gents requires the ATR kinase.
@en
P2093
Giancarlo Marra
Josef Jiricny
Massimiliano Di Pietro
Nina Mojas
Petr Cejka
P2860
P304
P356
10.1101/GAD.294404
P577
2004-06-01T00:00:00Z